Hallmarks of epithelial to mesenchymal transition are detectable in Crohn's disease associated intestinal fibrosis

被引:99
|
作者
Scharl, Michael [1 ,2 ]
Huber, Nicole [1 ]
Lang, Silvia [1 ]
Fuerst, Alois [3 ]
Jehle, Ekkehard [4 ]
Rogler, Gerhard [1 ,2 ]
机构
[1] Univ Zurich Hosp, Div Gastroenterol & Hepatol, Ramistr 100, CH-8091 Zurich, Switzerland
[2] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland
[3] Caritas Hosp St Josef, Dept Surg, Regensburg, Germany
[4] Oberschwaben Klin, Dept Surg, Ravensburg, Germany
来源
基金
瑞士国家科学基金会;
关键词
Crohn's disease; Epithelial-mesenchymal transition; Intestinal fibrosis;
D O I
10.1186/s40169-015-0046-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Intestinal fibrosis and subsequent stricture formation represent frequent complications of Crohn's disease (CD). In many organs, fibrosis develops as a result of epithelial to mesenchymal transition (EMT). Recent studies suggested that EMT could be involved in intestinal fibrosis as a result of chronic inflammation. Here, we investigated whether EMT might be involved in stricture formation in CD patients. Methods: Human colonic tissue specimens from fibrotic areas of 18 CD and 10 non-IBD control patients were studied. Immunohistochemical staining of CD68 (marker for monocytes/macrophages), transforming growth factor-beta(1) (TGF beta(1)), beta-catenin, SLUG, E-.cadherin, alpha-smooth muscle actin and fibroblast activation protein (FAP) were performed using standard techniques. Results: In fibrotic areas in the intestine of CD patients, a large number of CD68-positive mononuclear cells was detectable suggesting an inflammatory character of the fibrosis. We found stronger expression of TGF beta(1), the most powerful driving force for EMT, in and around the fibrotic lesions of CD patients than in non-IBD control patients. In CD patients membrane staining of beta-catenin was generally weaker than in control patients and more cells featured nuclear staining indicating transcriptionally active beta-catenin, in fibrotic areas. In these regions we also detected nuclear localisation of the transcription factor, SLUG, which has also been implicated in EMT pathogenesis. Adjacent to the fibrotic tissue regions, we observed high levels of FAP, a marker of reactive fibroblasts. Conclusions: We demonstrate the presence of EMT-associated molecules in fibrotic lesions of CD patients. These findings support the hypothesis that EMT might play a role for the development of CD-associated intestinal fibrosis.
引用
收藏
页数:9
相关论文
共 50 条
  • [11] Intestinal fibrosis is associated with lack of response to Infliximab therapy in Crohn's disease
    de Bruyn, Jessica R.
    Becker, Marte A.
    Steenkamer, Jessica
    Wildenberg, Manon E.
    Meijer, Sybren L.
    Buskens, Christianne J.
    Bemelman, Willem A.
    Lowenberg, Mark
    Ponsioen, Cyriel Y.
    van den Brink, Gijs R.
    D'Haens, Geert R.
    PLOS ONE, 2018, 13 (01):
  • [12] Epithelial down-regulation of the miR-200 family in fibrostenosing Crohn's disease is associated with features of epithelial to mesenchymal transition
    Mehta, Shameer J.
    Lewis, Amy
    Nijhuis, Anke
    Jeffery, Rosemary
    Biancheri, Paolo
    Di Sabatino, Antonio
    Feakins, Roger
    Silver, Andrew
    Lindsay, James Oliver
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2018, 22 (11) : 5617 - 5628
  • [13] Identification of Epithelial to Mesenchymal Transition as a Novel Source of Fibroblasts in Intestinal Fibrosis
    Tanjore, Harikrishna
    Flier, Sarah N.
    Kokkotou, Efi
    Sugimoto, Hikaru
    Zeisberg, Michael
    Kalluri, Raghu
    GASTROENTEROLOGY, 2010, 138 (05) : S752 - S752
  • [14] Identification of Epithelial to Mesenchymal Transition as a Novel Source of Fibroblasts in Intestinal Fibrosis
    Flier, Sarah N.
    Tanjore, Harikrishna
    Kokkotou, Efi G.
    Sugimoto, Hikaru
    Zeisberg, Michael
    Kalluri, Raghu
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (26) : 20202 - 20212
  • [15] Epithelial to mesenchymal transition is a hallmark of fibrostenosing Crohn's disease and is associated with down regulation of the miR-200 family
    Mehta, S. J.
    Lewis, A.
    Nijhuis, A.
    Jeffery, R.
    Feakins, R.
    Silver, A.
    Lindsay, J. O.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S91 - S92
  • [16] The immunological landscape of intestinal fibrosis in Crohn's Disease
    Jacobs, I.
    Creyns, B.
    Dragoni, G.
    Cremer, J.
    Bislenghi, G.
    D'Hoore, A.
    Ke, B. J.
    Matteoli, G.
    De Hertogh, G.
    Ferrante, M.
    Joao, G. S.
    Breynaert, C.
    Vermeire, S.
    Verstockt, B.
    Vanuytsel, T.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S168 - S169
  • [17] Total flavone of Abelmoschus manihot suppresses epithelial-mesenchymal transition via interfering transforming growth factor-β1 signaling in Crohn's disease intestinal fibrosis
    Bo-Lin Yang
    Ping Zhu
    You-Ran Li
    Min-Min Xu
    Hao Wang
    Li-Chao Qiao
    Hai-Xia Xu
    Hong-Jin Chen
    World Journal of Gastroenterology, 2018, 24 (30) : 3414 - 3425
  • [18] Total flavone of Abelmoschus manihot suppresses epithelial-mesenchymal transition via interfering transforming growth factor-β1 signaling in Crohn's disease intestinal fibrosis
    Yang, Bo-Lin
    Zhu, Ping
    Li, You-Ran
    Xu, Min-Min
    Wang, Hao
    Qiao, Li-Chao
    Xu, Hai-Xia
    Chen, Hong-Jin
    WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (30) : 3414 - 3425
  • [19] INTESTINAL EPITHELIAL MICROVILLI ARE ABNORMAL IN CROHN'S DISEASE
    VanDussen, Kelli L.
    Stojmirovic, Aleksandar
    Liu, Ta-Chiang
    Kimes, Patrick K.
    Perrigoue, Jacqueline G.
    Friedman, Joshua R.
    Towne, Jennifer E.
    Head, Richard D.
    Stappenbeck, Thaddeus S.
    INFLAMMATORY BOWEL DISEASES, 2018, 24 : S24 - S25
  • [20] INTESTINAL EPITHELIAL MICROVILLI ARE ABNORMAL IN CROHN'S DISEASE
    VanDussen, Kelli L.
    Aleksandar, Stojmirovi C.
    Liu, Ta-Chiang
    Kimes, Patrick K.
    Perrigoue, Jacqueline G.
    Friedman, Joshua R.
    Towne, Jennifer E.
    Head, Richard D.
    Stappenbeck, Thaddeus S.
    GASTROENTEROLOGY, 2018, 154 (01) : S35 - S35